This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Delhi Institute of Pharmaceutical Sciences and Research (Dipsar), Sentiss Pharma Private Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Shyam Sunder Agrawal: Innovator in Herbal Ophthalmic Formulations
Introduction
Shyam Sunder Agrawal is a notable inventor based in New Delhi, India. He has made significant contributions to the field of ophthalmology through his innovative research and development of herbal formulations. His work primarily focuses on addressing critical health issues such as glaucoma.
Latest Patents
Agrawal holds a patent for a synergistic herbal ophthalmic formulation aimed at lowering intraocular pressure in cases of glaucoma. This invention relates to a herbal composition that effectively reduces intraocular pressure across different types of glaucoma. The formulation is designed for preparation in pharmaceutically acceptable dosage forms, making it a valuable addition to the field of eye care.
Career Highlights
Throughout his career, Agrawal has worked with reputable organizations, including Sentiss Pharma Private Limited and the Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR). His experience in these institutions has allowed him to refine his skills and contribute to the advancement of pharmaceutical sciences.
Collaborations
Agrawal has collaborated with several professionals in his field, including Suresh Kumar Gupta and Renu Agrawal. These partnerships have facilitated the exchange of ideas and fostered innovation in his research endeavors.
Conclusion
Shyam Sunder Agrawal's contributions to herbal ophthalmic formulations highlight his commitment to improving healthcare solutions for glaucoma patients. His innovative approach and dedication to research continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile